Cell Sorting : Technological Advancement will Revolutionize the Global Healthcare Industry
The global cell sorting market is projected to reach USD 247.4 Million by 2021, at a CAGR of 7.0%
(firmenpresse) - According to a new market research report "Cell Sorting Market by Technology (FACS-based Droplet Sorting, MACS, Microfluidics), Product (Cell Sorters, Reagents, Consumables), Application (Research, Clinical), End User (Research Institutes, Biopharma Companies, Medical Schools) - Forecasts to 2021" published by MarketsandMarkets, this report studies the global cell sorting market over the forecast period of 2016 to 2021. The market is expected to reach USD 247.4 Million by 2021, at a CAGR of 7.0% from 2016 to 2021
Browse 67 market data Tables and 42 Figures spread through 167 Pages and in-depth TOC on "Cell Sorting Market".
The report analyzes and studies the major market drivers, restraints, opportunities, and challenges in North America, Europe, Asia-Pacific, and the Rest of the World (RoW).
A number of factors such as technological advancements in cell sorters, growing adoption of cell sorter techniques in research activities, rising funding and investments for development of innovative cell sorting techniques, growing prevalence of HIV/AIDS and cancer, and launch of specific reagents for specific applications are fueling the growth of the cell sorting market. On the other hand, lack of awareness and technical knowledge regarding the use of cell sorters and high cost of instruments are some of the key factors limiting the growth of the global cell sorting market.
On the basis of technology, the cell sorting market is broadly classified into three segments, namely, fluorescence-based droplet cell sorting, magnetic-activated cell sorting (MACS), and micro-electromechanical systems (MEMS)-microfluidics cell sorting technologies.
Download PDF Brochure@ https://www.marketsandmarkets.com/pdfdownload.asp?id=62606262
On the basis of product and service, the global cell sorting market is categorized into three major segments, namely, cell sorters, reagents & consumables, and services. On the basis of application, the cell sorting market is segmented into research applications and clinical applications. Based on end user, the cell sorting market is segmented into research institutions, academic institutions & medical schools, pharmaceutical & biotechnology companies, and hospitals & clinical testing laboratories.
Geographically, North America is expected to hold the largest share of the global cell sorting market in 2016, followed by Europe. However, the Asia-Pacific market is expected to register the highest CAGR during the forecast period. Factors such as growing prevalence of diseases such as cancer and HIV/AIDS, expansions by key players in APAC countries, and increasing research initiatives are stimulating the growth of the cell sorting market in the Asia-Pacific region.
The major players in the global Cell Sorting Market include Becton, Dickinson and Company (U.S.), Beckman Coulter, Inc. (U.S.), Bio-Rad Laboratories, Inc. (U.S.), Sony Biotechnology Inc. (U.S.), Miltenyi Biotec GmbH (Germany), Affymetrix Inc. (U.S.), Sysmex Partec GmbH (Japan), On-Chip Biotechnologies Co., Ltd. (Japan), Cytonome/ST, LLC (U.S.), and Union Biometrica, Inc. (U.S.).
Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=62606262
Weitere Infos zu dieser Pressemeldung:
Themen in dieser Pressemitteilung:
Unternehmensinformation / Kurzprofil:
MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies' revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.
Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model - GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.
MarketsandMarkets's flagship competitive intelligence and market research platform, "Knowledge Store" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.
Mr. Shelly Singh
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA: +1-888-600-6441
Email: sales(at)marketsandmarkets.com
![Erneut Auszeichnung von FOCUS MONEY \](/modules/PresseInfo/thump/fp_bwk.gif "Erneut Auszeichnung von FOCUS MONEY \")
Datum: 21.08.2019 - 12:02 Uhr
Sprache: Deutsch
News-ID 1746533
Anzahl Zeichen: 3433
Kontakt-Informationen:
Ansprechpartner: Dheeraj Shaha
Stadt:
Northbrook
Telefon: 18886006441
Kategorie:
Biotechnologie
Meldungsart: Finanzinformation
Versandart: Veröffentlichung
Freigabedatum: 21.08.2019
Diese Pressemitteilung wurde bisher 620 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Cell Sorting : Technological Advancement will Revolutionize the Global Healthcare Industry"
steht unter der journalistisch-redaktionellen Verantwortung von
MnM (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
The growth of this market is mainly driven by factors such as the increasing R&D expenditure in the pharmaceutical industry, increasing focus on miniaturization, technological advancements, and growing prevalence of diseases. The report "Microplate Systems Market by Product (Microplate R
3D Cell Culture Market : Regenerative Medicine to Offer Global Growth In Coming Years ...
A 3D cell culture is an artificially created environment in which biological cells are permitted to grow or interact with their surroundings in all three dimensions. Factors such as rising focus on developing alternative methods for animal testing, funding initiatives from government and private
Immuno Oncology Assays : Research Application Transforming the Industrial Business ...
What the Immuno Oncology Assays Market looks like? Growth in Immuno Oncology Assays Market is largely driven by factors such as the increasing adoption of targeted therapy over traditional therapy and the increasing demand for mAbs. According to the new market research report "Immuno Onco
Weitere Mitteilungen von MnM
Erneut Auszeichnung von FOCUS MONEY "Hohe Weiterempfehlung" ...
Basis dieser Auszeichnung ist eine breit angelegte Untersuchung von FOCUS MONEY und ServiceValue zum Empfehlungsverhalten von Kunden. Dabei kamen über 1200 Anbieter aus 82 Branchen auf den Prüfstand. 1.000 Teilnehmern wurden die Unternehmen in einem Online-Panel zur Bewertung angezeigt. Waren die
PDX Models - $167.6 Million Industry Business Expected in Basic Cancer Research ...
The key factors driving the growth of this market include the growing demand for personalized medicine, continuous support for cancer research from the public as well as private sectors, and growth in the number of R&D activities in the pharmaceutical industry. The growing use of humanized PDX m
Vink Chemicals erhöht die Produktionskapazität ...
Die Vink Chemicals GmbH & Co. KG hat kürzlich die ISP Biochema Schwaben GmbH in Memmingen (Bayern) übernommen. Diese Expansion erweitert die Produktionskapazität neben dem bereits bestehenden Produktionsstandort in Norddeutschland. Vink Chemicals erwirtschaftet rund 95 Prozent seines Umsatzes
Biosimulation Market to Register Substantial Expansion in Coming Years ...
The biosimulation market is expected to reach USD 2.88 billion by 2022 from USD 1.38 billion in 2017, growing at a CAGR of 15.9%. Factors such as the increase in R&D investments in the pharmaceutical and biotechnology industries, growing adoption of biosimulation software by regulatory bodies, t
